GlassScriptPhysician profile
Huawei Dong
NPI 1528346103
$44,349.61
in general payments reported to CMS, 2019-2025
16 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.35 · 2021: $183 · 2022: $6,692 · 2023: $9,666 · 2024: $13K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Food and Beverage: $3,478 · Travel and Lodging: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,385.00 |
| Food and Beverage | $3,478.12 |
| Travel and Lodging | $592.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $42,635.84 | 2021-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $694.91 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genentech USA, INC. | $237.48 | 2022-2023 | Xolair |
| Genzyme Corporation | $152.19 | 2025 | |
| United Therapeutics Corporation | $129.19 | 2021-2024 | Tyvaso |
| Baxter Healthcare | $109.01 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Genentech, INC. | $105.93 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $105.69 | 2021-2022 | |
| Philips North America LLC | $90.08 | 2019-2022 | |
| Verona Pharma, INC. | $34.73 | 2025 | Ohtuvayre |
| Pharming Healthcare, INC. | $21.95 | 2024 | Ruconest |
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2021 | |
| Insmed, INC. | $15.73 | 2025 | Arikayce |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huawei Dong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.